Capricor Therapeutics, Inc. (CAPR)
8.37
+0.07
(+0.84%)
USD |
NASDAQ |
Sep 11, 16:00
8.40
+0.03
(+0.36%)
After-Hours: 20:00
Capricor Therapeutics Price : 8.37 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 8.32 | 8.67 | 8.26 | 8.37 | 2.075M |
| Sep 10, 2026 | 8.575 | 8.70 | 8.182 | 8.30 | 2.917M |
| Sep 09, 2026 | 9.08 | 9.27 | 8.60 | 8.64 | 2.751M |
| Sep 08, 2026 | 9.15 | 9.488 | 8.81 | 9.06 | 2.728M |
| Sep 04, 2026 | 9.40 | 9.81 | 9.26 | 9.40 | 2.556M |
| Sep 03, 2026 | 9.83 | 9.93 | 9.14 | 9.28 | 4.065M |
| Sep 02, 2026 | 10.07 | 10.65 | 9.60 | 9.89 | 5.165M |
| Sep 01, 2026 | 10.77 | 11.00 | 9.85 | 10.01 | 6.309M |
| Aug 31, 2026 | 9.495 | 10.27 | 9.065 | 9.91 | 4.559M |
| Aug 28, 2026 | 9.73 | 10.20 | 9.47 | 9.59 | 5.186M |
| Aug 27, 2026 | 9.18 | 10.61 | 8.90 | 10.06 | 12.05M |
| Aug 26, 2026 | 8.29 | 9.88 | 8.05 | 9.36 | 12.04M |
| Aug 25, 2026 | 7.25 | 8.60 | 7.25 | 8.29 | 17.63M |
| Aug 24, 2026 | 8.03 | 8.03 | 6.34 | 6.80 | 20.09M |
| Aug 21, 2026 | 6.81 | 7.08 | 6.01 | 6.29 | 8.361M |
| Aug 20, 2026 | 7.66 | 7.82 | 6.83 | 6.835 | 8.109M |
| Aug 19, 2026 | 7.19 | 7.99 | 7.14 | 7.98 | 8.566M |
| Aug 18, 2026 | 7.50 | 8.29 | 6.764 | 7.08 | 8.539M |
| Aug 17, 2026 | 6.87 | 7.59 | 6.59 | 7.45 | 19.22M |
| Aug 14, 2026 | 7.66 | 8.15 | 6.04 | 6.65 | 66.33M |
| Aug 13, 2026 | 4.18 | 4.42 | 4.14 | 4.21 | 16.75M |
| Aug 12, 2026 | 3.95 | 4.30 | 3.90 | 4.19 | 2.753M |
| Aug 11, 2026 | 3.85 | 3.998 | 3.73 | 3.93 | 3.332M |
| Aug 10, 2026 | 4.04 | 4.105 | 3.805 | 3.85 | 3.089M |
| Aug 07, 2026 | 4.16 | 4.70 | 4.05 | 4.09 | 3.618M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| REGENXBIO, Inc. | 8.53 |
| Cytokinetics, Inc. | 73.77 |
| Emergent BioSolutions, Inc. | 6.23 |
| Rigel Pharmaceuticals, Inc. | 47.24 |
| United Therapeutics Corp. | 497.11 |
Price Related Metrics
| PEG Ratio | -0.0694 |
| Price to Book Value | 1.975 |
| Earnings Yield | -29.26% |
| Market Cap | 486.37M |
| PEGY Ratio | -0.0694 |